Diffuse Infiltrating Retinoblastoma with Anterior Chamber Involvement: Conservative Management and Identification of RB1 Alterations in Aqueous Humor.

IF 0.9 Q4 OPHTHALMOLOGY
Ocular Oncology and Pathology Pub Date : 2023-09-01 Epub Date: 2023-06-16 DOI:10.1159/000531233
Nathalie Cassoux, Denis Malaise, Livia Lumbroso-Le-Rouic, Jessica Le Gall, Lisa Golmard, Liesbeth Cardoen, Paul Freneaux, Yassine Bouchoucha, Isabelle Aerts, François Doz, Alexandre Matet
{"title":"Diffuse Infiltrating Retinoblastoma with Anterior Chamber Involvement: Conservative Management and Identification of <i>RB1</i> Alterations in Aqueous Humor.","authors":"Nathalie Cassoux, Denis Malaise, Livia Lumbroso-Le-Rouic, Jessica Le Gall, Lisa Golmard, Liesbeth Cardoen, Paul Freneaux, Yassine Bouchoucha, Isabelle Aerts, François Doz, Alexandre Matet","doi":"10.1159/000531233","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The aim of the study was to describe the successful conservative management of diffuse infiltrating retinoblastoma (DIR). Identification of <i>RB1</i> pathogenic variant was done after cell-free DNA (cfDNA) analysis in aqueous humor.</p><p><strong>Case presentation: </strong>Herein, we report 2 patients with unilateral, non-familial DIR with anterior and posterior involvement. Both patients underwent liquid biopsy for tumor cfDNA analysis in aqueous humor. Treatment consisted of a combination of systemic and intra-arterial chemotherapy, with consecutive intracameral and intravitreal injections of melphalan. One patient also required iodine-125 brachytherapy. In both cases, tumor cfDNA analysis revealed biallelic somatic alterations of the <i>RB1</i> gene. These alterations were not found in germline DNA. Both patients retained their eyes and had a useful vision after a follow-up of 2 years.</p><p><strong>Conclusion: </strong>In selected cases, conservative management of DIR is safe and effective. Tumor cfDNA analysis in aqueous humor is an effective technique to disclose <i>RB1</i> somatic alterations that guide the germline molecular explorations and improve genetic counseling after conservative treatment.</p>","PeriodicalId":19434,"journal":{"name":"Ocular Oncology and Pathology","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601847/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Oncology and Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000531233","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/16 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The aim of the study was to describe the successful conservative management of diffuse infiltrating retinoblastoma (DIR). Identification of RB1 pathogenic variant was done after cell-free DNA (cfDNA) analysis in aqueous humor.

Case presentation: Herein, we report 2 patients with unilateral, non-familial DIR with anterior and posterior involvement. Both patients underwent liquid biopsy for tumor cfDNA analysis in aqueous humor. Treatment consisted of a combination of systemic and intra-arterial chemotherapy, with consecutive intracameral and intravitreal injections of melphalan. One patient also required iodine-125 brachytherapy. In both cases, tumor cfDNA analysis revealed biallelic somatic alterations of the RB1 gene. These alterations were not found in germline DNA. Both patients retained their eyes and had a useful vision after a follow-up of 2 years.

Conclusion: In selected cases, conservative management of DIR is safe and effective. Tumor cfDNA analysis in aqueous humor is an effective technique to disclose RB1 somatic alterations that guide the germline molecular explorations and improve genetic counseling after conservative treatment.

前房受累的弥漫性浸润性视网膜母细胞瘤:体液RB1改变的保守治疗和鉴定。
引言:本研究的目的是描述弥漫性浸润性视网膜母细胞瘤(DIR)的成功保守治疗。在房水中进行无细胞DNA(cfDNA)分析后,对RB1致病性变体进行鉴定。病例介绍:在此,我们报告了2例单侧非家族性DIR患者,其前部和后部受累。两名患者均接受了房水中肿瘤cfDNA分析的液体活检。治疗包括全身和动脉内化疗的组合,以及连续的房内和玻璃体内注射美法仑。一名患者还需要碘-125近距离放射治疗。在这两种情况下,肿瘤cfDNA分析显示RB1基因的双等位基因体细胞改变。在种系DNA中没有发现这些改变。经过2年的随访,两名患者都保住了眼睛,视力良好。结论:在选定的病例中,DIR的保守治疗是安全有效的。房水中肿瘤cfDNA分析是揭示RB1体细胞改变的有效技术,可指导种系分子探索并改善保守治疗后的遗传咨询。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
0.00%
发文量
20
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信